Entera Bio ENTX
NASDAQ ENTX
$3.22 -0.02 (-0.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Entera Bio (ENTX) Current Leases (2019 - 2021)

Updated

Analysis

Entera Bio (ENTX) Current Leases (2019 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Entera Bio 563.51 Mn 269.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 179,000.00
Jun 30, 2021 184,000.00
Mar 31, 2021 182,000.00
Dec 31, 2020 189,000.00
Sep 30, 2020 167,000.00
Jun 30, 2020 169,000.00
Mar 31, 2020 152,000.00
Dec 31, 2019 177,000.00
API Access

Entera Bio Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ENTX&period=max&api_key=YOUR_API_KEY